SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-14-013858
Filing Date
2014-03-21
Accepted
2014-03-21 17:35:07
Documents
2
Period of Report
2014-03-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 2437
2 POWER OF ATTORNEY poa1.htm EX-24 10110
  Complete submission text file 0001140361-14-013858.txt   14189
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Issuer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2635 TECHNOLOGY FOREST BOULEVARD THE WOODLANDS TX 77381
Business Address
Hartung Hans-Peter (Reporting) CIK: 0001602913 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33004 | Film No.: 14711316